Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson’s Disease
Daniel F. Tardiff, Matthew C. Lucas, Iwona Wrona, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 4, pp. 2171-2189
Open Access | Times Cited: 22

Showing 22 citing articles:

SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors
Qin Sun, Xiaorui Xing, Huanyu Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115586-115586
Open Access | Times Cited: 44
Targeting de novo lipid synthesis induces lipotoxicity and impairs DNA damage repair in glioblastoma mouse models
Katharina M. Eyme, Alessandro Sammarco, Roshani Jha, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 679
Open Access | Times Cited: 35
Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents
Yachao He, Ibrahim Kaya, Mohammadreza Shariatgorji, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
Baoyi Li, Ulf Dettmer
Neurobiology of Disease (2024) Vol. 201, pp. 106646-106646
Open Access | Times Cited: 5
Lipidomics analysis in drug discovery and development
Sarantos Kostidis, Elena Sánchez‐López, Martin Giera
Current Opinion in Chemical Biology (2022) Vol. 72, pp. 102256-102256
Open Access | Times Cited: 21
Sulfamerazine as a Potential Modulator against α-Synuclein Aggregation and Associated Toxicity
Priyanka Singh, Nagesh Y. Kadam, Rajlaxmi Panigrahi, et al.
ACS Chemical Neuroscience (2025) Vol. 16, Iss. 5, pp. 880-894
Closed Access
Stearoyl–coenzyme A desaturase enhances cell survival in human uterine leiomyoma
Allison S. Komorowski, John S. Coon, Melania Lidia Anton, et al.
F&S Science (2025)
Open Access
Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models
Alessandro Sammarco, Giorgia Guerra, Katharina M. Eyme, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy
Natalia Siwecka, Kamil Saramowicz, Grzegorz Galita, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2051-2051
Open Access | Times Cited: 8
Association of serum oleic acid level with depression in American adults: a cross-sectional study
Jiahui Yin, Siyuan Li, Jinling Li, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Recent Advances in Clinical Trials in Multiple System Atrophy
David Bendetowicz, Margherita Fabbri, F. Sirna, et al.
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 4, pp. 95-112
Open Access | Times Cited: 2
A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
Silke Nuber, Chee Yeun Chung, Daniel F. Tardiff, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 3, pp. 1018-1036
Open Access | Times Cited: 12
A multimodal drug-diet-immunotherapy combination restrains melanoma progression and metastasis
Nicole Oatman, Mruniya V. Gawali, Sunny Congrove, et al.
Cancer Research (2024) Vol. 84, Iss. 14, pp. 2333-2351
Closed Access | Times Cited: 2
MUFA synthesis and stearoyl-CoA desaturase as a new pharmacological target for modulation of lipid and alpha-synuclein interaction against Parkinson's disease synucleinopathy
J. Kula, Katarzyna Kuter
Neuropharmacology (2024) Vol. 249, pp. 109865-109865
Closed Access | Times Cited: 1
Relationships between erythrocyte membrane mono- and poly- unsaturated fatty acid composition and clinical/cognitive indices in antipsychotic-free schizophrenia patients
Yuko Higuchi, Tsutomu Takahashi, Hiroko Itoh, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models
Alessandro Sammarco, Giorgia Guerra, Katharina M. Eyme, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ketogenic interventions restore cognition and modulate peripheral metabolic dysfunctions in Alzheimer's disease mouse models
Paule E. H. M’Bra, Laura K. Hamilton, Gaël Moquin‐Beaudry, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Fatty Acids as Potential Biomarkers of Stearoyl-Coa Desaturase Inhibition: Variation in Healthy Subjects and Parkinson's Disease Patients
Pepijn Eijsvogel, Andriy Gorbenko, Dan Tardiff, et al.
(2024)
Closed Access
Mass Spectrometry-Based Methods in CNS Drug Discovery
Gonzalo Blasco, Rudy Schreiber, Daan van Kruining
(2024), pp. 87-115
Closed Access
Divergent MEK/ERK and AMPK signaling dictate lipogenic plasticity and dependence on fatty acid synthesis in Glioblastoma
Katharina M. Eyme, Alessandro Sammarco, Roshani Jha, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Future Advances in Early Phase Clinical Development for Disease Modifying Therapies for Neurodegenerative Diseases
Philip Kremer, Geert Jan Groeneveld
Medical Research Archives (2022) Vol. 10, Iss. 9
Open Access
Page 1

Scroll to top